Menthol

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints. Specifically, it is effective for conditions such as simple backache, arthritis, muscle strains, bursitis, tendonitis, muscle sprains, bruises, and cramps.

Limitations of Use: There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 12 years and older, the recommended application involves peeling off the protective backing and applying the sticky side of the patch directly to the affected area. The backing should be carefully removed prior to application. Each patch is intended for use for a maximum duration of 8 hours. It is advised that the patch not be applied more than 3 to 4 times within a 24-hour period.

For children under 12 years of age, it is essential to consult a healthcare professional before use to determine appropriate dosing and administration.

Contraindications

Use of this product is contraindicated in the following situations:

Tight bandaging or the application of a heating pad is not recommended, as this may exacerbate adverse effects. Contact with eyes and mucous membranes should be avoided to prevent irritation or injury. Additionally, application to wounds or damaged skin is contraindicated due to the potential for increased sensitivity or adverse reactions.

Warnings and Precautions

EXTERNAL USE ONLY. This product is intended solely for topical application and should not be ingested.

General precautions must be observed to ensure safe use. It is imperative to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought by contacting a Poison Control Center at 1-800-222-1222.

Healthcare professionals should advise patients to discontinue use and seek medical attention under the following circumstances: if the condition worsens, if symptoms persist for more than 7 days, if symptoms resolve and then recur within a few days, if any redness is observed, or if skin irritation develops.

In cases of ingestion, it is crucial to obtain emergency medical help or contact a Poison Control Center immediately at 1-800-222-1222.

Side Effects

Patients should be aware that the product is for external use only. In the event that a patient's condition worsens, symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days, it is advised to discontinue use. Additionally, if redness is present or if skin irritation develops, patients should stop using the product immediately.

For patients who are pregnant or breastfeeding, it is recommended to consult a healthcare professional before using this product.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Cold and Hot Medicated Patch. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents and adults aged 12 years and older, the medication may be administered up to every 8 hours, with a maximum frequency of 3 to 4 times daily.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. The potential risks and benefits must be carefully considered in these populations. There is limited data available regarding the effects of this medication on fetal outcomes or during lactation, and therefore, healthcare providers should exercise caution and provide appropriate counseling to women of childbearing potential.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication if they are pregnant or breastfeeding. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, healthcare providers should evaluate the potential risks and benefits before recommending its use in lactating individuals.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any unusual symptoms or adverse effects that may arise. In the event of suspected overdosage, it is recommended to initiate supportive care and symptomatic treatment as necessary.

Healthcare providers should consider contacting a poison control center or a medical toxicologist for guidance on management strategies tailored to the individual case. Continuous assessment of the patient's clinical status is essential to ensure appropriate interventions are implemented promptly.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should seek medical assistance or contact a Poison Control Center immediately at 1-800-222-1222.

Patients must be instructed to use the medication only as directed. They should be cautioned against bandaging the area tightly or using a heating pad in conjunction with the treatment. It is important to avoid contact with the eyes and mucous membranes, and patients should not apply the medication to wounds or damaged skin.

For patients who are pregnant or breastfeeding, it is essential to recommend consulting a healthcare professional before using the medication.

Patients should be informed to monitor their condition closely and to seek medical advice if any of the following occur: if the condition worsens, if symptoms persist for more than 7 days, if symptoms clear up and then recur within a few days, if redness is present, or if skin irritation develops.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature, maintaining a range of 68° to 77°F (20° to 25°C) to ensure its stability and efficacy. Proper storage conditions must be adhered to, as deviations from the recommended temperature range may compromise the product's integrity.

Additional Clinical Information

The product is administered topically and should be applied for a maximum duration of 8 hours, not exceeding 3 to 4 applications per day. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. It is crucial to keep the product out of reach of children; in the event of ingestion, immediate medical assistance or contact with a Poison Control Center (1-800-222-1222) is recommended.

No additional information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Cold and Hot Medicated Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)